Observational studyAnnals of hematology2024

A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan.

Yuichi Horigome et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.